Housing mice near vs. below thermoneutrality affects drug-induced weight loss but does not improve prediction of efficacy in humans
Cell Reports · 2024-08 · 43 (8) · 114501
DOI: 10.1016/j.celrep.2024.114501 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2024-08. Verfasst von Julie M Jacobsen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Obesity and Liver Pharmacology, Integrated Physiology Research, Novo Nordisk A/S, Bagsværd, Denmark. Hauptthemen laut MEDLINE: Weight Loss. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Intramural NIH HHS, Novo Nordisk A/S, National Institutes of Health.
Abstract (Originalsprache)
Evaluation of weight loss drugs is usually performed in diet-induced obese mice housed at ∼22°C. This is a cold stress that increases energy expenditure by ∼35% compared to thermoneutrality (∼30°C), which may overestimate drug-induced weight loss. We investigated five anti-obesity mechanisms that have been in clinical development, comparing weight loss in mice housed at 22°C vs. 30°C. Glucagon-like peptide-1 (GLP-1), human fibroblast growth factor 21 (hFGF21), and melanocortin-4 receptor (MC4R) agonist induced similar weight losses. Peptide YY elicited greater vehicle-subtracted weight loss at 30°C (7.2% vs. 1.4%), whereas growth differentiation factor 15 (GDF15) was more effective at 22°C (13% vs. 6%). Independent of ambient temperature, GLP-1 and hFGF21 prevented the reduction in metabolic rate caused by weight loss. There was no simple rule for a better prediction of human drug efficacy based on ambient temperature, but since humans live at thermoneutrality, drug testing using mice should include experiments near thermoneutrality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Obesity and Liver Pharmacology, Integrated Physiology Research, Novo Nordisk A/S, Bagsværd, Denmark.
- Liver and Gut Biology, Obesity & NASH, Global Drug Discovery, Novo Nordisk A/S, Bagsværd, Denmark.
- Translational Medicine, Global Translation, Novo Nordisk A/S, Bagsværd, Denmark.
- Diabetes, Obesity and NASH, Global Drug Discovery, Novo Nordisk A/S, Bagsværd, Denmark.
- Lead Portfolio Projects, Research and Early Development, Novo Nordisk A/S, Bagsværd, Denmark.
- Large Animal Pharmacology, Global Drug Discovery, Novo Nordisk A/S, Bagsværd, Denmark.
Förderung
- Intramural NIH HHS
- Novo Nordisk A/S
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Jacobsen, J. M., Petersen, N., Torz, L., Gerstenberg, M. K., Pedersen, K., Østergaard, S., Wulff, B. S., Andersen, B., Raun, K., Christoffersen, B. Ø., John, L. M., Reitman, M. L., & Kuhre, R. E. (2024). Housing mice near vs. below thermoneutrality affects drug-induced weight loss but does not improve prediction of efficacy in humans. Cell Reports, 43(8), 114501. https://doi.org/10.1016/j.celrep.2024.114501
Vancouver
Jacobsen JM, Petersen N, Torz L, Gerstenberg MK, Pedersen K, Østergaard S, et al. Housing mice near vs. below thermoneutrality affects drug-induced weight loss but does not improve prediction of efficacy in humans. Cell Reports. 2024;43(8):114501. doi:10.1016/j.celrep.2024.114501
BibTeX
@article{Jacobsen2024,
author = {Jacobsen, Julie M and Petersen, Natalia and Torz, Lola and Gerstenberg, Marina K and Pedersen, Kent and Østergaard, Søren and Wulff, Birgitte S and Andersen, Birgitte and Raun, Kirsten and Christoffersen, Berit Ø and John, Linu M and Reitman, Marc L and Kuhre, Rune E},
title = {Housing mice near vs. below thermoneutrality affects drug-induced weight loss but does not improve prediction of efficacy in humans},
journal = {Cell Reports},
year = {2024},
volume = {43},
number = {8},
pages = {114501},
doi = {10.1016/j.celrep.2024.114501}
}
EUVIMED